SCHEMBL5613312

SCHEMBL5613312

CCCCCCCCCCCCCCCC=C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.54
TSHR P16473 3/20 0.48
THRB P10828 1/20 0.44
FAAH O00519 3/20 0.42
TRPV1 Q8NER1 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
TERT O14746 3/20 0.41
MAPT P10636 2/20 0.41
BLM P54132 2/20 0.41
HSD17B10 Q99714 2/20 0.41
FABP4 P15090 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613199 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613189 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613340 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL72975 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613352 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL2729508 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL83372 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL1416712 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613296 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL28120005 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270521-A1 Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
EP-0748823-A1 Catalyst composition and process for the production of olefinic polymers NIPPON OIL CO. LTD. (JP) 1996-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270521-A1 Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer CARM1, CPN1, CCNT1 EP300 1453/4885TSHR 4291/4885THRB 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.